Financial Highlights – Lee's Pharmaceutical

Investors

Fact Sheet

Financial Highlights

Year ended 31 December
HK$'000
2018
2017
Changes
Revenue
1,137,626
1,008,522
+ 12.8%
Gross Profit
746,371
682,404
+ 9.4%
Gross Profit Margin (%)
65.6%
67.7%
- 2.1 pp
EBITDA
532,013
334,935
+ 58.8%
Profit from Operations
466,936
276,828
+ 68.7%
Profit attributable to shareholders of the Company
418,269
232,559
+ 79.9%
Basic EPS (HK cents)
70.67
39.38
+ 79.5%
Diluted EPS (HK cents)
70.28
39.26
+ 79.0%
Total Dividend per Share (HK cents) (Interim + Final)
11.8
10.4
+ 13.5%